Drug intelligence / Profile preview

morus nigra pulp extract

Development stage
Preclinical
Administration
Oral
01

Overview

Morus nigra pulp extract is a botanical preparation derived from the fruit of the black mulberry tree (*Morus nigra* L.). It is characterized by a high content of secondary metabolites, particularly flavonoids, which confer significant antioxidant and anti-inflammatory properties. In preclinical models of sepsis, the extract has demonstrated therapeutic potential by reducing systemic inflammatory responses, including the lowering of tumor necrosis factor (TNF) levels and the inhibition of matrix metalloproteinase-2 (MMP-2) activity. Furthermore, it modulates oxidative stress by decreasing the activity of antioxidant enzymes such as glutathione peroxidase, which may reflect a reduction in the overall reactive species burden. These combined biological actions have been shown to improve survival rates in experimental models of systemic inflammation.

Other names
black mulberry pulp extractMorus nigra L. pulp extract
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))MMP2 (Matrix metalloproteinase-2)GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on morus nigra pulp extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morus nigra pulp extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call